4.7 Article

CDKL5 localizes at the centrosome and midbody and is required for faithful cell division

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-017-05875-z

关键词

-

资金

  1. Italian Association for Cancer Research (AIRC) [14592, 17739]
  2. Italian Foundation for Cancer Research (FIRC) [GGP10032]
  3. Lejeune Foundation
  4. EU Initial Training Network program [238242]
  5. Albero di Greta

向作者/读者索取更多资源

The cyclin-dependent kinase-like 5 (CDKL5) gene has been associated with rare neurodevelopmental disorders characterized by the early onset of seizures and intellectual disability. The CDKL5 protein is widely expressed in most tissues and cells with both nuclear and cytoplasmic localization. In post-mitotic neurons CDKL5 is mainly involved in dendritic arborization, axon outgrowth, and spine formation while in proliferating cells its function is still largely unknown. Here, we report that CDKL5 localizes at the centrosome and at the midbody in proliferating cells. Acute inactivation of CDKL5 by RNA interference (RNAi) leads to multipolar spindle formation, cytokinesis failure and centrosome accumulation. At the molecular level, we observed that, among the several midbody components we analyzed, midbodies of CDKL5-depleted cells were devoid of HIPK2 and its cytokinesis target, the extrachromosomal histone H2B phosphorylated at S14. Of relevance, expression of the phosphomimetic mutant H2B-S14D, which is capable of overcoming cytokinesis failure in HIPK2-defective cells, was sufficient to rescue spindle multipolarity in CDKL5-depleted cells. Taken together, these results highlight a hitherto unknown role of CDKL5 in regulating faithful cell division by guaranteeing proper HIPK2/H2B functions at the midbody.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

The Aurora-A/TPX2 Axis Directs Spindle Orientation in Adherent Human Cells by Regulating NuMA and Microtubule Stability

Federica Polverino, Francesco D. Naso, Italia A. Asteriti, Valentina Palmerini, Divya Singh, Davide Valente, Alexander W. Bird, Alessandro Rosa, Marina Mapelli, Giulia Guarguaglini

Summary: Mitotic spindle orientation is a crucial process in cell division, with Aurora-A and TPX2 playing key roles in regulating NuMA localization and spindle alignment. The interaction between TPX2 and Aurora-A is necessary for proper spindle orientation, and both Aurora-A and TPX2 levels can impact the stability of microtubules and spindle orientation.

CURRENT BIOLOGY (2021)

Article Oncology

HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer

Alessandra Verdina, Micol Di Segni, Carla Amoreo, Isabella Sperduti, Simonetta Buglioni, Marcella Mottolese, Giuliana Di Rocco, Silvia Soddu

Summary: The study suggests that HIPK2 may serve as a potential predictive marker for adjuvant-treated stage II CRC and for prospective therapy with NRF2 modulators, as high percentage of HIPK2(+) cells was associated with therapeutic vulnerability in stage II CRC. Additionally, HIPK2 depletion induced resistance to 5-FU and OXA, while sensitivity to these drugs was further induced by brusatol supplementation in HIPK2-proficient cells.

ONCOLOGY REPORTS (2021)

Review Biochemistry & Molecular Biology

Turning the spotlight on the oligosaccharide chain of GM1 ganglioside

Elena Chiricozzi, Erika Di Biase, Giulia Lunghi, Maria Fazzari, Nicoletta Loberto, Massimo Aureli, Laura Mauri, Sandro Sonnino

Summary: Glycosphingolipids have been a focus of research for over a century, with particular attention to the monosialylated glycosphingolipid GM1 in recent years. Studies on the functional roles of the oligosaccharide OligoGM1 have shed new light on its importance for neuronal functions and its potential in modifying the progression of Parkinson's disease in preclinical studies.

GLYCOCONJUGATE JOURNAL (2021)

Article Cell Biology

Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties

Rossella Luca, Maria Rita Assenza, Fabio Maiullari, Luisa Pieroni, Silvia Maiullari, Giulia Federici, Federica Marini, Roberto Rizzi, Andrea Urbani, Silvia Soddu, Fabiola Moretti

Summary: MDM4 impairs the metastatic process of EOC by inhibiting mTOR activity, reducing cell migration. High levels of MDM4 expression are associated with significantly increased 15-year survival rate and negative impact on the efficacy of mTOR inhibitors.

CELL DEATH & DISEASE (2021)

Review Biochemistry & Molecular Biology

Novel insights on GM1 and Parkinson's disease: A critical review

Maria Fazzari, Erika Di Biase, Giulia Lunghi, Laura Mauri, Elena Chiricozzi, Sandro Sonnino

Summary: This review discusses the role of GM1 in the pathogenesis of Parkinson's disease and proposes additional mechanisms that need further investigation.

GLYCOCONJUGATE JOURNAL (2022)

Article Neurosciences

Identification of Region-Specific Cytoskeletal and Molecular Alterations in Astrocytes of Mecp2 Deficient Animals

Elena Albizzati, Elena Florio, Federica Miramondi, Irene Sormonta, Nicoletta Landsberger, Angelisa Frasca

Summary: This study investigated the cytoskeletal features of astrocytes in Mecp2 deficient brains and found that Mecp2 deficiency causes structural and molecular alterations in astrocytes. These alterations progress with the severity of symptoms and occur differently in different cerebral regions, highlighting the importance of considering heterogeneity when studying astrocytes in Rett syndrome.

FRONTIERS IN NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition

Maria Fazzari, Giulia Lunghi, Elena Chiricozzi, Laura Mauri, Sandro Sonnino

Summary: Gangliosides are glycosphingolipids that are abundant in mammalian neuron plasma membranes and have neurotrophic and neuroprotective properties. However, their clinical use is limited due to poor penetrability and an association with Guillain-Barre syndrome.

BIOMEDICINES (2022)

Article Genetics & Heredity

Not Just Loss-of-Function Variations Identification of a Hypermorphic Variant in a Patient With a CDKL5 Missense Substitution

Angelisa Frasca, Efterpi Pavlidou, Matteo Bizzotto, Yunan Gao, Dario Balestra, Mirko Pinotti, Hans Atli Dahl, Nicholas D. Mazarakis, Nicoletta Landsberger, Maria Kinali

Summary: CDKL5 deficiency disorder is a neurodevelopmental disorder caused by variations in the X-linked CDKL5 gene, with clinical consequences generally attributed to loss-of-function variations. We identified a female patient with mild epilepsy carrying a novel nucleotide substitution that leads to hyperactivation of CDKL5. This highlights the importance of tight control of CDKL5 activity in the brain.

NEUROLOGY-GENETICS (2022)

Article Cell Biology

Blockage of autophagosome-lysosome fusion through SNAP29 O-GlcNAcylation promotes apoptosis via ROS production

Francesca Romana Pellegrini, Sara De Martino, Giulia Fianco, Irene Ventura, Davide Valente, Mario Fiore, Daniela Trisciuoglio, Francesca Degrassi

Summary: This study identified a new pathway in autophagy connecting O-GlcNAcylated SNAP29 to autophagic flux blockage and autophagosome accumulation, which leads to ROS production and apoptotic cell death. These findings provide a new opportunity for therapeutic intervention in cancer and other autophagy-related diseases.

AUTOPHAGY (2023)

Review Oncology

Factors to Consider for the Correct Use of γH2AX in the Evaluation of DNA Double-Strand Breaks Damage Caused by Ionizing Radiation

Davide Valente, Maria Pia Gentileschi, Antonino Guerrisi, Vicente Bruzzaniti, Aldo Morrone, Silvia Soddu, Alessandra Verdina

Summary: This article discusses the induction of gamma H2AX in individuals exposed to ionizing radiation and its applications in clinical studies. By analyzing the various conditions that induce H2AX phosphorylation and describing commonly used methods for gamma H2AX determination, the assessment of DSBs following IR exposure can be optimized.

CANCERS (2022)

Article Clinical Neurology

New cellular imaging-based method to distinguish the SPG4 subtype of hereditary spastic paraplegia

Francesca Sardina, Davide Valente, Gaia Fattorini, Ettore Cioffi, Gianmarco Dalla Zanna, Alessandra Tessa, Daniela Trisciuoglio, Silvia Soddu, Filippo M. Santorelli, Carlo Casali, Cinzia Rinaldo

Summary: The study developed an automated, simple, fast, and non-invasive cell imaging-based method to quantify microtubule cytoskeleton organization changes in lymphoblastoid cells and peripheral blood mononuclear cells. The results showed that individuals affected by SPG4-hereditary spastic paraplegia have a polarized microtubule cytoskeleton organization. The method was able to discriminate SPG4-hereditary spastic paraplegia from healthy donors and other subtypes, and detect the effects of spastin protein level changes.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Review Neurosciences

Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives

Michela Palmieri, Diego Pozzer, Nicoletta Landsberger

Summary: Loss and gain of functions mutations in the X-linked MECP2 gene cause severe neurological disorders. There is currently no cure for MECP2 related disorders, but re-expression of the wild-type gene has shown promise in restoring defective phenotypes. Gene therapy and genome editing technologies are being explored as potential treatments, and clinical trials have been approved for augmentative gene therapy.

FRONTIERS IN NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP

Maria Fazzari, Giulia Lunghi, Alexandre Henriques, Noelle Callizot, Maria Grazia Ciampa, Laura Mauri, Simona Prioni, Emma Veronica Carsana, Nicoletta Loberto, Massimo Aureli, Luigi Mari, Sandro Sonnino, Elena Chiricozzi, Erika Di Biase

Summary: Past evidence suggests that GM1 ganglioside administration can slow neuronal death in preclinical models of Parkinson's disease. However, the limitations of GM1's physical and chemical properties prevent its clinical application due to the blood-brain barrier. Recent research has shown that the GM1 oligosaccharide head group (GM1-OS) promotes neuronal differentiation, protection, and reparation by interacting with the TrkA-NGF complex. In Parkinson's disease-linked neurotoxin MPTP models, GM1-OS administration enhanced mitochondrial function, reduced oxidative stress, and increased neuronal survival.

BIOMEDICINES (2023)

Meeting Abstract Biochemistry & Molecular Biology

Biophysical studies to understand GM1-α-synuclein interaction

Laura Mauri, Giulia Lunghi, Maria Fazzari, Maria Grazia Ciampa, Caterina Ricci, Tim Bartles, Elena Chiricozzi, Francesca Vasile, Monica Civera

JOURNAL OF NEUROCHEMISTRY (2022)

Meeting Abstract Biochemistry & Molecular Biology

GM1 oligosaccharide as a novel neuroprotective agent for amyotrophic lateral sclerosis

M. Fazzari, A. Henriques, G. Lunghi, L. Mauri, M. G. Ciampa, G. Tedeschi, N. Mitro, S. Sonnino, M. Spedding, E. Chiricozzi

FEBS OPEN BIO (2022)

暂无数据